Immuno Cure Holding (HK) Limited
+852 2682 0299
Mr. Dominic Wan
The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
Immuno Cure Holding (HK) Limited is a biotechnology group focusing on its patented technology platforms for the research and development of immunotherapy for cancers, inflammatory and infectious diseases. The patented technology platforms comprise a PD-1 based DNA vaccine technology platform to target various infectious diseases and cancers as well as an anti-PD-1 isoform antibody to suppress inflammation.
The Group is based in Hong Kong Science Park and Shenzhen with an experienced management team and a group of partners with expertise in the DNA vaccine ecosystem, including R&D institution, CDMO, electroporation device technology, DNA vaccine manufacturing process technology, CRO and GMP manufacturer.
Utilizing the two technology platforms, the Group has developed a list of pipelines for the HIV and cancer treatments as well as COVID-19 prevention.